H|T: The Healthtech Times – AbCellera denies patent infringement, Waystar eyes $8B valuation
Plus: Truepill moves to cut share price by 90 percent.
Plus: Truepill moves to cut share price by 90 percent.
Led by Relay Ventures and VTS VPs, $2-million VC fund looks to leverage its LP battalion of Canadian tech operators.
Oncology tech firm closed a $20-million round and led an $18-million Supercluster project in 2022.
Deadline to apply for OBIO’s Women in Health Initiative is September 10.
PointClickCare expands marketplace of integrated solutions with PatientPay.
Plus: Peloton launches new approach to B2B service.
Doctor-backed Calgary startup sees opportunities across Alberta.
Plus: US Senator questions ethics of Google’s Med-PaLM 2.
Plus: Silofit closes its doors, VoxNeuro raises $4.5M to scale brain performance.
Trio joins growing list of Canadian tech firms that have restructured or ceased operating during the downturn.
Plus: Vital Bioscience reveals desktop blood tester with big backers.
Plus: Halifax’s 3D BioFibR secures $3.52M for automated collagen fibre manufacturing.
After the bloody mess at Theranos, Vital is among the new wave of startups developing accessible diagnostics.
Dialogue will maintain its head office in Montréal and operate as a standalone entity as part of Sun Life Canada.